223 related articles for article (PubMed ID: 16051786)
1. The brains behind blockbusters.
Couzin J
Science; 2005 Jul; 309(5735):728. PubMed ID: 16051786
[No Abstract] [Full Text] [Related]
2. Surviving the blockbuster syndrome.
Service RF
Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490
[No Abstract] [Full Text] [Related]
3. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
Federsel HJ
Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
[TBL] [Abstract][Full Text] [Related]
4. The pharmaceutical industry--to whom is it accountable?
Hayes TA
N Engl J Med; 2000 Nov; 343(19):1416; discussion 1417. PubMed ID: 11183881
[No Abstract] [Full Text] [Related]
5. Cutting the cost of drug development?
Rawlins MD
Nat Rev Drug Discov; 2004 Apr; 3(4):360-4. PubMed ID: 15060531
[No Abstract] [Full Text] [Related]
6. Pharma moves ahead cautiously in China.
Yidong G
Science; 2005 Jul; 309(5735):735. PubMed ID: 16051788
[No Abstract] [Full Text] [Related]
7. [Research projects of pharmaceutical companies].
Okuyama S
Nihon Yakurigaku Zasshi; 2008 Aug; 132(2):77-8. PubMed ID: 18792463
[No Abstract] [Full Text] [Related]
8. Scripps Florida.
Sheppard TL
Nat Chem Biol; 2007 Aug; 3(8):451. PubMed ID: 17637772
[TBL] [Abstract][Full Text] [Related]
9. Pharma goes to work. Introduction.
Mervis J
Science; 2005 Jul; 309(5735):721. PubMed ID: 16051780
[No Abstract] [Full Text] [Related]
10. The end of the beginning?
Nat Rev Drug Discov; 2006 Sep; 5(9):705. PubMed ID: 17001798
[No Abstract] [Full Text] [Related]
11. The state of innovation in drug development.
Kola I
Clin Pharmacol Ther; 2008 Feb; 83(2):227-30. PubMed ID: 18202690
[TBL] [Abstract][Full Text] [Related]
12. Drug discovery alliances.
Jones A; Clifford L
Nat Rev Drug Discov; 2005 Oct; 4(10):807-8. PubMed ID: 16237845
[No Abstract] [Full Text] [Related]
13. The lost science of formulation.
Brown MB
Drug Discov Today; 2005 Nov; 10(21):1405-7. PubMed ID: 16243254
[No Abstract] [Full Text] [Related]
14. The hunt for a new drug: five views from the inside.
Mervis J
Science; 2005 Jul; 309(5735):722. PubMed ID: 16051781
[No Abstract] [Full Text] [Related]
15. Research group forswears financial ties to firms whose drugs it tests.
Holden C
Science; 1989 Apr; 244(4902):282. PubMed ID: 2652299
[No Abstract] [Full Text] [Related]
16. Biomarkers: a valuable tool in clinical research and medical practice.
Carini C
IDrugs; 2007 Jun; 10(6):395-8. PubMed ID: 17642003
[TBL] [Abstract][Full Text] [Related]
17. Opinion: anticipating change in drug development: the emerging era of translational medicine and therapeutics.
Fitzgerald GA
Nat Rev Drug Discov; 2005 Oct; 4(10):815-8. PubMed ID: 16224453
[TBL] [Abstract][Full Text] [Related]
18. Success in an uneven market.
Russo E
Nature; 2003 Jul; 424(6948):597. PubMed ID: 12891372
[No Abstract] [Full Text] [Related]
19. Deal watch: Trends in platform technology deal-making.
Walker J; Jacob J
Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
[No Abstract] [Full Text] [Related]
20. From lab bench to Wall Street.
Bartfai T
FASEB J; 2006 Aug; 20(10):1578-80. PubMed ID: 16873880
[No Abstract] [Full Text] [Related]
[Next] [New Search]
